Skip to main content

Life sciences consulting

The ultimate test. The need to get new drugs to market faster is critical; so too is the need to control costs and protect public safety.

Our view: Bringing a pharmaceutical or biologic product to market takes more than just good science. It takes an agile business to respond to the changing market dynamics.

Read the IBM Institute for Business Value report: The new biopharmaceutical blueprint: Aligning business and IT with service-oriented architecture

What we offer

Business solutions

Deep industry expertise provides the foundation for solving the most complex business problems.

Real results

Bayer helps develop the cures of the future with electronic capture of clinical trial data.

  • Paul Papas

    "Life sciences companies are innovation based at their core and the rapidly changing healthcare ecosystem requires them to not only bring new and innovative treatments to market, but to rethink their internal and external business models."

    Paul Papas
    Americas Life Sciences Leader, IBM Global Business Services

Related offerings

We're here to help

Easy ways to get the answers you need.


Or call us at:
1-800-IBM-7080
Mention US7AN05T

IDEAWATCHPharma

Life sciences insights and commentary from across the industry and around the world.


The Global CFO Study 2008

Balancing risk and performance with an Integrated Finance Organization.


Global Human Capital Study 2008

Unlocking the DNA of the adaptable workforce.


Application management - a global benchmark

Learn how to respond rapidly to today's economic conditions.